Silicon Valley Capital Partners’s AbbVie ABBV Stock Holding History

Silicon Valley Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$126K	Buy	580 +35	+6%	+$7.76K	0.01%	112
2025 Q4	$125K	Sell	545 -10	-2%	-$2.28K	0.01%	104
2025 Q3	$129K	Sell	555 -34	-6%	-$6.92K	0.01%	103
2025 Q2	$109K	Buy	589 +16	+3%	+$2.97K	0.01%	101
2025 Q1	$118K	Buy	573 +56	+11%	+$10.9K	0.02%	96
2024 Q4	$91.8K	Sell	517 -198	-28%	-$36.4K	0.01%	107
2024 Q3	$141K	Sell	715 -6	-0.8%	-$1.12K	0.02%	85
2024 Q2	$124K	Sell	721 -41	-5%	-$6.79K	0.02%	87
2024 Q1	$139K	Sell	762 -158	-17%	-$27.2K	0.02%	77
2023 Q4	$143K	Sell	920 -132	-13%	-$19.2K	0.02%	74
2023 Q3	$157K	Sell	1,052 -105	-9%	-$15.4K	0.03%	70
2023 Q2	$156K	Sell	1,157 -100	-8%	-$14.7K	0.03%	75
2023 Q1	$200K	Sell	1,257 -62	-5%	-$9.48K	0.04%	68
2022 Q4	$213K	Buy	+1,319	New	+$202K	0.05%	66
2022 Q3	–	Sell	-1,475	Closed	-$226K	–	66
2022 Q2	$226K	Sell	1,475 -49	-3%	-$7.49K	0.05%	58
2022 Q1	$247K	Buy	1,524 +8	+0.5%	+$1.16K	0.04%	64
2021 Q4	$205K	Buy	+1,516	New	+$179K	0.03%	75
2021 Q2	–	Sell	-1,978	Closed	-$214K	–	62
2021 Q1	$214K	Sell	1,978 -114	-5%	-$12.2K	0.05%	64
2020 Q4	$224K	Buy	+2,092	New	+$201K	0.05%	56

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Silicon Valley Capital Partners's ABBV Position: Q1 2026 in Review

Silicon Valley Capital Partners increased its AbbVie (ABBV) stake by 6.4% in Q1 2026, buying an estimated $7.76K and bringing the position to 580 shares worth $126K. The position accounts for 0.01% of the portfolio, ranked #112.

Silicon Valley Capital Partners first reported a position in ABBV in Q4 2020 and has held it in 19 quarters since. The position peaked at $247K in Q1 2022. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Silicon Valley Capital Partners held 580 shares of AbbVie worth $126K as of Q1 2026.
Silicon Valley Capital Partners bought 35 AbbVie shares in Q1 2026, an estimated $7.76K.
AbbVie made up 0.01% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #112 holding.
Silicon Valley Capital Partners first reported a position in AbbVie in Q4 2020 and has held it in 19 quarters since.
Silicon Valley Capital Partners's AbbVie position peaked at $247K in Q1 2022.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.